Circulating Tumor Cells Enumeration from the Portal Vein for Risk Stratification in Early Pancreatic Cancer Patients.
Javier Padillo-RuizGonzalo SuarezSheila PereiraFrancisco José Calero-CastroJose TinocoLuis MarinCarmen Bernal-BellidoCarmen Cepeda-FrancoJosé María Álamo-MartínezFrancisco AlmogueraHada C MacherPaula VillanuevaFrancisco José García-FernandezInmaculada GallegoManuel RomeroMiguel Ángel Gómez-BravoValeria DenninghoffMaría José SerranoPublished in: Cancers (2021)
CTC presence in PV could be an important prognostic factor to predict poor prognosis in early pancreatic cancer. In addition, the number of clustered-CTC correlate to a tumor negative differentiation degree and, therefore, could be used as a diagnostic biomarker for pancreatic cancer.